Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of peroral levosimendan in the prevention of further hospitalisations in patients with chronic heart failure
2004-004225-10Phase 2Completed
- Sponsor
- Orion Corporation
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic heart failure (CHF) comparing Levosimendan with Placebo (2 arms). Primary endpoint: Patient Journey composite endpoint. Started Dec 2004; status: completed.
02
Drugs
levosimendan
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on 2004-004225-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004225-10.